Ad is loading...
GREZX vs MGLIX
GREZX vs MGLIX Comparison
Open Charts GREZX vs MGLIX
GuideStone Funds Global Rl Est Secs I
Price$9.20
Change-$0.08 (-0.86%)
VolumeN/A
Net Assets293.19M
MFS Global Real Estate I
Price$15.97
Change-$0.15 (-0.93%)
VolumeN/A
Net Assets2.25B
GREZX vs MGLIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
GREZX vs. MGLIX commentary
May 15, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GREZX is a Buy and MGLIX is a Buy.
FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.25B vs. GREZX (293M). MGLIX pays higher dividends than GREZX: MGLIX (2.60) vs GREZX (2.33). GREZX was incepted earlier than MGLIX: GREZX (18 years) vs MGLIX (16 years). GREZX (1.23) is less costly to investors than MGLIX (0.95). GREZX is a more actively managed with annual turnover of: 153.00 vs. MGLIX (48.00). MGLIX has a lower initial minimum investment than GREZX: MGLIX (0) vs GREZX (1000). GREZX annual gain was more profitable for investors over the last year : 10.04 vs. MGLIX (3.24). GREZX return over 5 years is better than : 36.85 vs. MGLIX (28.67).
| GREZX | MGLIX | GREZX / MGLIX | |
| Total Expense Ratio | 1.23 | 0.94 | 131% |
| Annual Report Gross Expense Ratio | 1.23 | 0.95 | 129% |
| Fund Existence | 18 years | 16 years | - |
| Gain YTD | 3.996 | 1.559 | 256% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 293M | 2.25B | 13% |
| Annual Yield % from dividends | 2.33 | 2.60 | 90% |
| Returns for 1 year | 10.04 | 3.24 | 310% |
| Returns for 3 years | 1.88 | -7.84 | -24% |
| Returns for 5 years | 36.85 | 28.67 | 129% |
| Returns for 10 years | 21.44 | 24.77 | 87% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VALIX | 13.18 | 0.21 | +1.62% |
| Value Line Capital Appreciation Investor | |||
| JAGLX | 64.76 | N/A | N/A |
| Janus Henderson Global Life Sciences T | |||
| RYSVX | 185.37 | N/A | N/A |
| Rydex S&P SmallCap 600 Pure Value A | |||
| FGEAX | 24.89 | N/A | N/A |
| Fidelity Advisor Glbl Capital Apprec A | |||
| JEMGX | 9.89 | N/A | N/A |
| JHancock Emerging Markets Equity R6 | |||